Amundi Asset Management US’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $970M | Buy |
2,125,367
+321,378
| +18% | +$153M | 0.74% | 20 |
|
|
2020
Q4 | $840M | Buy |
1,803,989
+3,818
| +0.2% | +$1.79M | 0.71% | 23 |
|
|
2020
Q3 | $795M | Buy |
1,800,171
+58,178
| +3% | +$24M | 0.83% | 19 |
|
|
2020
Q2 | $631M | Buy |
1,741,993
+187,070
| +12% | +$62.7M | 0.75% | 23 |
|
|
2020
Q1 | $441M | Sell |
1,554,923
-190,225
| -11% | -$60M | 0.77% | 24 |
|
|
2019
Q4 | $567M | Buy |
1,745,148
+351,257
| +25% | +$107M | 0.66% | 28 |
|
|
2019
Q3 | $406M | Sell |
1,393,891
-399,718
| -22% | -$114M | 0.61% | 28 |
|
|
2019
Q2 | $527M | Sell |
1,793,609
-258,138
| -13% | -$71.1M | 0.43% | 63 |
|
|
2019
Q1 | $562M | Sell |
2,051,747
-191,604
| -9% | -$47.7M | 0.79% | 21 |
|
|
2018
Q4 | $502K | Sell |
2,243,351
-29,833
| -1% | -$7M | 0.46% | 32 |
|
|
2018
Q3 | $555M | Buy |
2,273,184
+83,988
| +4% | +$19.3M | 0.73% | 22 |
|
|
2018
Q2 | $453M | Buy |
2,189,196
+238,343
| +12% | +$50.6M | 0.65% | 27 |
|
|
2018
Q1 | $403M | Sell |
1,950,853
-235,144
| -11% | -$49.4M | 0.65% | 24 |
|
|
2017
Q4 | $415M | Sell |
2,185,997
-61,961
| -3% | -$11.9M | 0.64% | 30 |
|
|
2017
Q3 | $425M | Buy |
2,247,958
+5,492
| +0.2% | +$995K | 1.35% | 13 |
|
|
2017
Q2 | $391M | Buy |
2,242,466
+23,381
| +1% | +$3.93M | 1.28% | 18 |
|
|
2017
Q1 | $341M | Buy |
2,219,085
+34,012
| +2% | +$5.2M | 1.15% | 20 |
|
|
2016
Q4 | $308M | Sell |
2,185,073
-460,164
| -17% | -$67.8M | 1.08% | 24 |
|
|
2016
Q3 | $421M | Buy |
2,645,237
+51,433
| +2% | +$7.93M | 1.51% | 8 |
|
|
2016
Q2 | $383M | Buy |
2,593,804
+240,059
| +10% | +$35.4M | 1.39% | 14 |
|
|
2016
Q1 | $333M | Buy |
2,353,745
+110,697
| +5% | +$14.8M | 1.24% | 16 |
|
|
2015
Q4 | $318M | Buy |
2,243,048
+46,926
| +2% | +$6.26M | 1.19% | 15 |
|
|
2015
Q3 | $269M | Buy |
2,196,122
+24,994
| +1% | +$3.26M | 1.1% | 17 |
|
|
2015
Q2 | $282M | Buy |
2,171,128
+32,142
| +2% | +$4.19M | 1.03% | 14 |
|
|
2015
Q1 | $287M | Buy |
2,138,986
+173,850
| +9% | +$22.4M | 1.03% | 14 |
|
|
2014
Q4 | $246M | Sell |
1,965,136
-20,395
| -1% | -$2.48M | 0.89% | 18 |
|
|
2014
Q3 | $242M | Buy |
1,985,531
+61,959
| +3% | +$7.53M | 0.91% | 16 |
|
|
2014
Q2 | $227M | Buy |
1,923,572
+72,718
| +4% | +$8.56M | 0.87% | 17 |
|
|
2014
Q1 | $223M | Sell |
1,850,854
-49,953
| -3% | -$5.94M | 0.85% | 25 |
|
|
2013
Q4 | $212M | Buy |
1,900,807
+29,077
| +2% | +$2.89M | 0.81% | 24 |
|
|
2013
Q3 | $172M | Buy |
1,871,730
+44,093
| +2% | +$3.99M | 0.7% | 35 |
|
|
2013
Q2 | $155M | Buy |
+1,827,637
| New | +$152M | 0.64% | 37 |
|
Other funds holding TMO
Amundi Asset Management US's TMO Position: Q1 2021 in Review
Amundi Asset Management US increased its Thermo Fisher Scientific (TMO) stake by 18% in Q1 2021, buying an estimated $153M and bringing the position to 2,125,367 shares worth $970M. The position accounts for 0.74% of the portfolio, ranked #20.
Amundi Asset Management US first reported a position in TMO in Q2 2013 and has held it in 32 quarters since. 2,042 funds tracked by Wall St. Rank hold TMO as of Q1 2021.
- Amundi Asset Management US held 2,125,367 shares of Thermo Fisher Scientific worth $970M as of Q1 2021.
- Amundi Asset Management US bought 321,378 Thermo Fisher Scientific shares in Q1 2021, an estimated $153M.
- Thermo Fisher Scientific made up 0.74% of Amundi Asset Management US's portfolio in Q1 2021, its #20 holding.
- Amundi Asset Management US first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 32 quarters since.
- 2,042 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2021.
Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.